secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lyell Immunopharma, Inc. (LYEL)
CIK:        0001806952
Form:       8-K
Filed at:   2022-06-13T23:59:59+00:00
Accession:  0001193125-22-172997
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Lyell Immunopharma annual meeting elects Class I directors, ratifies auditor
----------------------------------------------------------------------------

- Elected Hans Bishop, Catherine Friedman, Robert Nelsen as Class I directors; each received >147M votes for.
- Ratified Ernst & Young LLP as independent auditor for FY2022; 192.2M for, 1,241 against.
- Quorum achieved with 192,242,640 shares (77.79%) present at June 8, 2022 annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1806952/000119312522172997/0001193125-22-172997-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1806952/000119312522172997/d357559d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-172997

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer